Evolent Health Inc (EVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($15.81 Million) by net assets ($842.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evolent Health Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EVH current and long-term liabilities for a breakdown of total debt and financial obligations.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hitron Technologies Inc
TW:2419
|
-0.018x |
|
Reconnaissance Energy Africa Ltd
V:RECO
|
-0.022x |
|
NVE Corporation
NASDAQ:NVEC
|
0.047x |
|
Bell Financial Group Ltd
AU:BFG
|
0.132x |
|
Kingsway Financial Services Inc
NYSE:KFS
|
0.041x |
|
Selena FM S.A.
WAR:SEL
|
0.139x |
|
CapsoVision, Inc. Common Stock
NASDAQ:CV
|
-0.580x |
|
FS Bancorp Inc
NASDAQ:FSBW
|
0.040x |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see EVH market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, anal… Read more